Skip to content

Addiction: all studies

Page 790 of 857: studies 7,891 to 7,900 of 8,563, newest first. Back to the addiction overview

Research

Human Pharmacology of 3,4-Methylenedioxymeth-amphetamine ("Ecstasy"): Psychomotor Performance and Subjective Effects

Journal of Clinical Psychopharmacology August 1, 2000 Jordi Camı́, Magı́ Farré, Marta Más et al. 237 citations

3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") is a recreational drug of increasing use among youth because of its apparent entactogenic properties, such as euphoria, friendliness, closeness, and empathy. However, experimental studies have shown MDMA to be neurotoxic. Data on pharmacologic actions of MDMA in humans are limited. The authors conducted a randomized, double-blind, crossover,...

Interactions between iboga agents and methamphetamine sensitization: studies of locomotion and stereotypy in rats.

Psychopharmacology August 1, 2000 Karen K. Szumlinski, M Y Balogun, Isabelle M Maisonneuve et al. 28 citations

The phenomenon of sensitization has been theoretically implicated in mediating various aspects of drug addiction. Recent dose-response studies demonstrated that pretreatment with the putative antiaddictive agent, ibogaine (IBO), and a synthetic iboga alkaloid congener, 18-methoxycoronaridine (18-MC), increase the potency of cocaine to elicit behavioral sensitization, an effect proposed to...

DOI: 10.1007/s002130000478 (opens in new tab) Full text (opens in new tab) Stimulant misuse methamphetamine Stimulants Drug self-administration Chronic methamphetamine exposure +11

Long-lasting ibogaine protection against NMDA-induced convulsions in mice.

Neurochemical Research August 1, 2000 M B Leal, D O De Souza, E Elisabetsky 23 citations

Ibogaine, a putative antiaddictive drug, is remarkable in its apparent ability to downgrade withdrawal symptoms and drug craving for extended periods of time after a single dose. Ibogaine acts as a non-competitive NMDA receptor antagonist, while NMDA has been implicated in long lasting changes in neuronal function and in the physiological basis of drug addiction. The purpose of this study was...

DOI: 10.1023/a:1007665911622 (opens in new tab) Full text (opens in new tab) Ibogaine: ibogaine Drug withdrawal Craving Neuropharmacology: brain receptors +6

The development and expression of locomotor sensitization to nicotine in the presence of ibogaine.

Behavioural Pharmacology August 1, 2000 C Zubaran, M Shoaib, I P Stolerman 7 citations

Ibogaine is a naturally occurring psychoactive alkaloid with claimed efficacy in the treatment of certain drug addictions, including nicotine. It has been reported to be a non-competitive blocker of nicotinic receptors, with a potent inhibitory action on nicotinic acetylcholine receptor-mediated catecholamine release. We have investigated the effect of different doses of ibogaine on the...

Subjective Conceptions

Metaphor and Moral Experience July 20, 2000 A. E. Denham

AbstractGenuine moral judgements might be only available to someone possessed of moral competence, and moral competence requires, at a minimum, that one be susceptible to a specific kind of moral experience — the experience of others' concerns and interests as valuable. That experience, in turn, requires that one be able to conceive of others' purposes as from their subjective point of view, a...

Blockade of phencyclidine-induced effects by a nitric oxide donor.

British Journal of Pharmacology July 1, 2000 M Bujas-Bobanovic, D C Bird, H A Robertson et al.

1. Phencyclidine (PCP) is widely used as an animal model of schizophrenia. The aim of this study was to better understand the role of nitric oxide (NO) in the mechanism of action of PCP and to determine whether positive NO modulators may provide a new approach to the treatment of schizophrenia. 2. The effects of the NO donor, sodium nitroprusside (SNP), were studied in PCP-treated rats....

Evaluating Hallucinogenic or Psychedelic Drug Intoxication in an Emergency Setting

July 1, 2000 Robert H. Williams, T. Erickson

Under certain conditions or in an overdose setting, several classes of drugs can induce illusions, hallucinations, or delusions. However, one of the hallmark features of hallucinogens or psychedelic agents is their ability to induce states of altered or distorted perception, thought, and mood. Many hallucinogens produce classic sympathomimetic effects; that is, hyperactivity, mydriasis (dilated...

N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine (MBDB): its properties and possible risks.

Addiction Biology July 1, 2000 L A Aerts, M Mallaret, H Rigter 12 citations

Abstract MBDB (N -methyl-1-(1,3-benzodioxol-5-yl)-2-aminobutane) is the alpha-ethyl homologue of MDMA (3,4-methylenedioxy-N-methylamphetamine). MBDB is metabolized and excreted similarly to MDMA: presumably, the majority of oral MBDB is excreted in urine unmetabolized.The main metabolic routes in man are thought to be O-dealkylation and subsequent methylation, sulphation and glucuronidation of...

Differential effects of ibogaine on behavioural and dopamine sensitization to cocaine.

European Journal of Pharmacology June 16, 2000 Karen K. Szumlinski, Isabelle M Maisonneuve, Stanley D Glick 19 citations

To investigate a possible basis for the proposed anti-addictive property of ibogaine, the effects of ibogaine (40 mg/kg, i.p., 19 h earlier) on the expression of sensitization induced by cocaine were investigated. Ibogaine pretreatment potentiated the increase in the stereotypic effects of a cocaine challenge (20 mg/kg) in both sensitized (5 x 15 mg/kg, i.p.) and acutely treated rats. However,...

A neurofunctional theory of visual consciousness.

Consciousness and Cognition June 1, 2000 J Prinz

This paper develops an empirically motivated theory of visual consciousness. It begins by outlining neuropsychological support for Jackendoff's (1987) hypothesis that visual consciousness involves mental representations at an intermediate level of processing. It then supplements that hypothesis with the further requirement that attention, which can come under the direction of high level...